NLNan Lv

Nan Lv

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nan Lv has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Shuyu Zhao

    Department of Endocrinology, Second Affiliated Hospital of Harbin Medical University

    2 shared publications
  • Tianyi Liu

    Department of Endocrinology, Second Affiliated Hospital of Harbin Medical University

    2 shared publications
  • Yan Li

    Department of Endocrinology, Second Affiliated Hospital of Harbin Medical University

    2 shared publications
  • Huifang Cong

    Department of Gynecology, Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China

    1 shared publication
  • Jiantao Sun

    Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China

    1 shared publication
  • Jiemei Yang

    Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Inference of Molecular Subtypes of Uterine Corpus Endometrioid Carcinoma with Different Survival Based on Cancer Hallmarks-associated Long Non-Coding RNAs and Gene Modules

    by Nan Lv, Shuyu Zhao, Yan Li, Tianyi Liu, Xiaodan Chu

    Background: Uterine corpus endometrioid carcinoma (UCEC), a common gynecological malignancy with high incidence, affects the mental and physical health of women. It is increasingly evident that long non-coding RNAs (lncRNAs) have causative roles in cancers including UCEC. However, very little is known about the cancer hallmark-related risks for UCEC based on lncRNAs and genes. Methods: In this study, a computational integrated pipeline was development to evaluate cancer hallmark-related risk for each UCEC patient based on gene and lncRNA expression. Results: Some UCEC-specific cancer hallmark-related genes and lncRNAs were identified. Core modules were extracted from co-expressed UCEC-specific lncRNAs and genes networks for each cancer hallmark. Some core modules showed specific features and functions. Follow a multi-dimensional rank approach and core modules, each UCEC sample was given an integrated cancer hallmark-related risk score. We divided all the UCEC patients to diverse hallmark risk groups including multi-hallmark, media-hallmark and single-hallmark groups and they showed different prognosis. We also identified some key lncRNAs which participated in multiple kinds of cancer hallmarks. These key lncRNAs were associated with some essential pathways such as estrogen receptor signaling. Conclusions: In conclusion, the present study provide novel insights to the classification and treatment of UCEC.

  • Open Access

    Construction of Glycometabolism- and Hormone-Related lncRNA-Mediated Feedforward Loop Networks Reveals Global Patterns of lncRNAs and Drug Repurposing in Gestational Diabetes

    by Xuelian Fu, Huifang Cong, Shuyu Zhao, Yan Li, Tianyi Liu, Yuhong Sun, Nan Lv

    Gestational diabetes mellitus (GDM) is a condition associated with the onset of abnormal glucose tolerance during pregnancy. Long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and genes can form lncRNA-mediated feedforward loops (lnc-FFLs), which are functional network motifs that regulate a wide range of biological processes and diseases. However, lnc-FFL network motifs have not been systematically investigated in GDM, and their role in the disease remains largely unknown. In the present study, a global lnc-FFL network was constructed and analyzed. Glycometabolism- and hormone-related lnc-FFL networks were extracted from the global network. An integrated algorithm was designed to identify dysregulated glycometabolism- and hormone-related lnc-FFLs in GDM. The patterns of dysregulated lnc-FFLs in GDM were complex. Moreover, there were strong associations between dysregulated glycometabolism- and hormone-related lnc-FFLs in GDM. Core modules were extracted from the dysregulated lnc-FFL networks in GDM and showed specific and essential functions. In addition, dysregulated lnc-FFLs could combine with ceRNAs and form more complex modules, which could play novel roles in GDM. Notably, we discovered that the dysregulated lnc-FFLs were enriched in the thyroid hormone signaling pathway. Some drug-repurposing candidates, such as hormonal drugs, could be identified based on lnc-FFLs in GDM. In summary, the present study highlighted the effect of dysregulated glycometabolism- and hormone-related lnc-FFLs in GDM and revealed their potential for the discovery of novel biomarkers and therapeutic targets for GDM.


  • Open Access

    Identification and characterization of methylation-mediated transcriptional dysregulation dictate methylation roles in preeclampsia

    by Shuyu Zhao, Nan Lv, Yan Li, Tianyi Liu, Yuhong Sun, Xiaodan Chu

    Preeclampsia (PE) is a heterogeneous, hypertensive disorder of pregnancy, with no robust biomarkers or effective treatments. PE increases the risk of poor outcomes for both the mother and the baby. Methylation-mediated transcriptional dysregulation motifs (methTDMs) could contribute the PE development. However, precise functional roles of methTDMs in PE have not been globally described. Here, we develop a comprehensive and computational pipeline to identify PE-specific methTDMs following TF, gene, methylation expression profile, and experimentally verified TF-gene interactions. The regulation patterns of methTDMs are multiple and complex in PE and contain relax inhibition, intensify inhibition, relax activation, intensify activation, reverse activation, and reverse inhibition. A core module is extracted from global methTDM network to further depict the mechanism of methTDMs in PE. The common and specific features of any two kinds of regulation pattern are also analyzed in PE. Some key methylation sites, TFs, and genes such as IL2RG are identified in PE. Functional analysis shows that methTDMs are associated with immune-, insulin-, and NK cell-related functions. Drug-related network identifies some key drug repurposing candidates such as NADH. Collectively, the study highlighted the effect of methylation on the transcription process in PE. MethTDMs could contribute to identify specific biomarkers and drug repurposing candidates for PE.


  • Open Access

    Identification of drug repurposing candidates based on a miRNA-mediated drug and pathway network for cardiac hypertrophy and acute myocardial infarction

    by Jiantao Sun, Jiemei Yang, Jing Chi, Xue Ding, Nan Lv

    Cardiac hypertrophy and acute myocardial infarction (AMI) are two common heart diseases worldwide. However, research is needed into the exact pathogenesis and effective treatment strategies for these diseases. Recently, microRNAs (miRNAs) have been suggested to regulate the pathological pathways of heart disease, indicating a potential role in novel treatments. In our study, we constructed a miRNA-gene-drug network and analyzed its topological features. We also identified some significantly dysregulated miRNA-gene-drug triplets (MGDTs) in cardiac hypertrophy and AMI using a computational method. Then, we characterized the activity score profile features for MGDTs in cardiac hypertrophy and AMI. The functional analyses suggested that the genes in the network held special functions. We extracted an insulin-like growth factor 1 receptor-related subnetwork in cardiac hypertrophy and a vascular endothelial growth factor A-related subnetwork in AMI. Finally, we considered insulin-like growth factor 1 receptor and vascular endothelial growth factor A as two candidate drug targets by utilizing the cardiac hypertrophy and AMI pathways. These results provide novel insights into the mechanisms and treatment of cardiac hypertrophy and AMI.